Sudipta Sonar

Employment

• Translational Health Science and Technology Institute Project Associate II
  2020 - Present
• National AIDS Research Institute Junior Research Fellow
  2019 - 2020

Education

• ICMR-National Institute of Virology Master of Science
  2017 - 2019
• Savitribai Phule Pune University Bachelor of Technology
  2012 - 2016

Projects & Funding

Projects & funding information is unavailable.

Publications (10)

• Targeting DPP4-RBD interactions by sitagliptin and linagliptin delivers a potential host-directed therapy against pan-SARS-CoV-2 infections.
  International journal of biological macromolecules 2023 DOI: 10.1016/j.ijbiomac.2023.125444
  +Save
• Trends of humoral immune responses to heterologous antigenic exposure due to vaccination & omicron SARS-CoV-2 infection: Implications for boosting.
  The Indian journal of medical research 2023 DOI: 10.4103/ijmr.ijmr_2521_22
  +Save
• A broadly neutralizing monoclonal antibody overcomes the mutational landscape of emerging SARS-CoV-2 variants of concern.
  PLoS pathogens 2022 DOI: 10.1371/journal.ppat.1010994
  +Save
• Characterization of a broadly cross reactive tetravalent human monoclonal antibody, recognizing conformational epitopes in receptor binding domain of SARS-CoV-2.
  3 Biotech 2022 DOI: 10.1007/s13205-022-03272-6
  +Save
• A combination of potently neutralizing monoclonal antibodies isolated from an Indian convalescent donor protects against the SARS-CoV-2 Delta variant.
  PLoS pathogens 2022 DOI: 10.1371/journal.ppat.1010465
  +Save
• High failure rate of ChAdOx1-nCoV19 immunization against asymptomatic infection in healthcare workers during a Delta variant surge.
  Nature communications 2022 DOI: 10.1038/s41467-022-29404-3
  +Save
• The SARS CoV-2 spike directed non-neutralizing polyclonal antibodies cross-react with Human immunodeficiency virus (HIV-1) gp41.
  International immunopharmacology 2021 DOI: 10.1016/j.intimp.2021.108187
  +Save
• Characterization of the NiRAN domain from RNA-dependent RNA polymerase provides insights into a potential therapeutic target against SARS-CoV-2.
  PLoS computational biology 2021 DOI: 10.1371/journal.pcbi.1009384
  +Save
• Non-neutralizing SARS CoV-2 directed polyclonal antibodies demonstrate cross-reactivity with the HA glycans of influenza virus.
  International immunopharmacology 2021 DOI: 10.1016/j.intimp.2021.108020
  +Save
• Comparative Immunomodulatory Evaluation of the Receptor Binding Domain of the SARS-CoV-2 Spike Protein; a Potential Vaccine Candidate Which Imparts Potent Humoral and Th1 Type Immune Response in a Mouse Model.
  Frontiers in immunology 2021 DOI: 10.3389/fimmu.2021.641447
  +Save